* Volrustomig combination found unlikely to meet main goals * Company also reports positive readouts from two other late-stage lung cancer trials * Other Phase III volrustomig trials to continue as
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
ByteDance signs AI copyright pact with Hollywood trade group
Aug 17 (Reuters) - ByteDance and the Motion Picture Association on Monday signed an agreement…
Banks reach $86.4 million Mexican bond rigging settlement in Manhattan
NEW YORK, Aug 17 (Reuters) - Mexican banking affiliates of Bank of America, Banco Santander,…
Four countries, multiple identities, secret radio broadcasts, wartime missions, and a submarine crossing, recreated for…
